Tomohiro Morishige

650 total citations
19 papers, 544 citations indexed

About

Tomohiro Morishige is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Tomohiro Morishige has authored 19 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Genetics. Recurrent topics in Tomohiro Morishige's work include Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (7 papers) and Immunotherapy and Immune Responses (6 papers). Tomohiro Morishige is often cited by papers focused on Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (7 papers) and Immunotherapy and Immune Responses (6 papers). Tomohiro Morishige collaborates with scholars based in Japan, China and United States. Tomohiro Morishige's co-authors include Naoki Okada, Yohei Mukai, Shinsaku Nakagawa, Xinglei Yao, Yasuo Tsutsumi, Shin‐ichi Tsunoda, Aya Tanabe, Yasuo Yoshioka, Yasuo Yoshioka and Yusuke Eto and has published in prestigious journals such as Biomaterials, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Tomohiro Morishige

19 papers receiving 540 citations

Peers

Countries citing papers authored by Tomohiro Morishige

Since Specialization

Citations

This map shows the geographic impact of Tomohiro Morishige's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Morishige with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Morishige more than expected).

Fields of papers citing papers by Tomohiro Morishige

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Morishige. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Morishige. The network helps show where Tomohiro Morishige may publish in the future.

Co-authorship network of co-authors of Tomohiro Morishige

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Morishige. A scholar is included among the top collaborators of Tomohiro Morishige based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Morishige. Tomohiro Morishige is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Mutants of lymphotoxin-α with augmented cytotoxic activity via TNFR1 for use in cancer therapy 2012 ·Cytokine ·Tomohiro Morishige, Yasuo Yoshioka, (unknown), Shinji Ikemizu, Shin‐ichi Tsunoda, Yasuo Tsutsumi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	3
2	Suppression of nanosilica particle-induced inflammation by surface modification of the particles 2012 ·Archives of Toxicology ·Tomohiro Morishige, Yasuo Yoshioka, (unknown), Aya Tanabe, (unknown), Xinglei Yao, Youko Monobe, Takayoshi Imazawa, Shin‐ichi Tsunoda, Yasuo Tsutsumi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	39
3	Lysine-deficient lymphotoxin-α mutant for site-specific PEGylation 2011 ·Cytokine ·(unknown), Yasuo Yoshioka, Hikaru Watanabe, (unknown), Tomohiro Morishige, Xinglei Yao, Aya Tanabe, Shin‐ichi Tsunoda, Yasuo Tsutsumi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	3
4	Tumor Vascular Targeted Delivery of Polymer-conjugated Adenovirus Vector for Cancer Gene Therapy 2011 ·Molecular Therapy ·Xinglei Yao, Yasuo Yoshioka, Tomohiro Morishige, Yusuke Eto, (unknown), Yasuaki Kawai, Hiroyuki Mizuguchi, Jianqing Gao, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	28
5	Structure–activity relationship of T-cell receptors based on alanine scanning 2011 ·Biochemical and Biophysical Research Communications ·(unknown), Yasuo Yoshioka, Tomohiro Morishige, Xinglei Yao, Shin‐ichi Tsunoda, Yasuo Tsutsumi, Michael I. Nishimura, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	2
6	Titanium dioxide induces different levels of IL-1β production dependent on its particle characteristics through caspase-1 activation mediated by reactive oxygen species and cathepsin B 2010 ·Biochemical and Biophysical Research Communications ·Tomohiro Morishige, Yasuo Yoshioka, Aya Tanabe, Xinglei Yao, Shin‐ichi Tsunoda, Yasuo Tsutsumi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	80
7	Creation of a lysine-deficient LIGHT mutant with the capacity for site-specific PEGylation and low affinity for a decoy receptor 2010 ·Biochemical and Biophysical Research Communications ·Tomohiro Morishige, Yasuo Yoshioka, (unknown), Aya Tanabe, Xinglei Yao, Shin‐ichi Tsunoda, Yasuo Tsutsumi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	9
8	Creation of a LIGHT mutant with the capacity to evade the decoy receptor for cancer therapy 2010 ·Biomaterials ·Tomohiro Morishige, Yasuo Yoshioka, (unknown), Aya Tanabe, Xinglei Yao, Shin‐ichi Tsunoda, Yasuo Tsutsumi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	13
9	The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1β production, ROS production and endosomal rupture 2010 ·Biomaterials ·Tomohiro Morishige, Yasuo Yoshioka, (unknown), Aya Tanabe, Xinglei Yao, (unknown), Youko Monobe, Takayoshi Imazawa, Shin‐ichi Tsunoda, Yasuo Tsutsumi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	130
10	Adenovirus Vector Covalently Conjugated to Polyethylene Glycol with a Cancer-Specific Promoter Suppresses the Tumor Growth through Systemic Administration 2010 ·Biological and Pharmaceutical Bulletin ·Xinglei Yao, Yasuo Yoshioka, Tomohiro Morishige, Yusuke Eto, (unknown), Hiroyuki Mizuguchi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	8
11	Cytotoxicity of amorphous silica particles against macrophage-like THP-1 cells depends on particle-size and surface properties. 2010 ·PubMed ·Tomohiro Morishige, Yayoi Yoshioka, (unknown), Aya Tanabe, Xiongliang Yao, Shin‐ichi Tsunoda, Yasuhiko Tsutsumi, Yohei Mukai, Naoki Okada, Shino Nakagawa	20
12	Optimized PEGylated Adenovirus Vector Reduces the Anti-vector Humoral Immune Response against Adenovirus and Induces a Therapeutic Effect against Metastatic Lung Cancer 2010 ·Biological and Pharmaceutical Bulletin ·Yusuke Eto, Yasuo Yoshioka, Tatsuhiro Ishida, Xinglei Yao, Tomohiro Morishige, (unknown), Hiroyuki Mizuguchi, Yohei Mukai, Naoki Okada, Hiroshi Kiwada, Shinsaku Nakagawa	25
13	LIGHT protein suppresses tumor growth by augmentation of immune response 2009 ·Immunology Letters ·Tomohiro Morishige, Yasuo Yoshioka, (unknown), Aya Tanabe, Hikaru Watanabe, Xinglei Yao, Shin‐ichi Tsunoda, Yasuo Tsutsumi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	7
14	Creation of lysine-deficient mutant lymphotoxin-α with receptor selectivity by using a phage display system 2009 ·Biomaterials ·Yasuo Yoshioka, Hikaru Watanabe, Tomohiro Morishige, Xinglei Yao, Shinji Ikemizu, Chioko Nagao, Shandar Ahmad, Kenji Mizuguchi, Shin‐ichi Tsunoda, Yasuo Tsutsumi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	13
15	Comparison of the anti-tumor activity of native, secreted, and membrane-bound LIGHT in mouse tumor models 2009 ·International Immunopharmacology ·Tomohiro Morishige, Yasuo Yoshioka, Aya Tanabe, Xinglei Yao, Hiroyuki Mizuguchi, Shin‐ichi Tsunoda, Yasuo Tsutsumi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	3
16	Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis 2009 ·Gene Therapy ·Xingang Yao, Yasuo Yoshioka, Tomohiro Morishige, Yusuke Eto, Hikaru Watanabe, Yoshinori Okada, Hiroyuki Mizuguchi, Yohei Mukai, Naoki Okada, Satoshi Nakagawa	40
17	Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency 2008 ·Life Sciences ·Yasuo Yoshioka, (unknown), Yusuke Eto, Hikaru Watanabe, Tomohiro Morishige, Xinglei Yao, Shinya Kida, Mitsuko Maeda, Yohei Mukai, Hiroyuki Mizuguchi, Koichi Kawasaki, Naoki Okada, Shinsaku Nakagawa	15
18	TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection 2007 ·Biochemical and Biophysical Research Communications ·Xinglei Yao, Yasuo Yoshioka, Yusuke Eto, Tomohiro Morishige, Yuka Okada, Hiroyuki Mizuguchi, Yohei Mukai, Naoki Okada, Shinsaku Nakagawa	16
19	Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration 2007 ·Journal of Controlled Release ·Jianqing Gao, Yusuke Eto, Yasuo Yoshioka, Fumiko Sekiguchi, Shinnosuke Kurachi, Tomohiro Morishige, Xinglei Yao, Hikaru Watanabe, (unknown), Fuminori Sakurai, Hiroyuki Mizuguchi, Yuka Okada, Yohei Mukai, Yasuo Tsutsumi, Tadanori Mayumi, Naoki Okada, Shinsaku Nakagawa	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact